Skip to main content
. 2022 Jul 12;297:115528. doi: 10.1016/j.jep.2022.115528

Table 1.

Docking results for 23 small molecule compounds against the targets of SARS-CoV-2 (Mpro, PLpro, Nsp3AMP, Nsp3MES, RdRp RTP, Nsp14N7-MTase, Nsp16GTA, Nsp16MGP, Nsp16SAM).

Compou.No. M pro PL pro Nsp3 AMP Nsp3 MES RDRP RTP Nsp14N7
-MTase
Nsp16 GTA Nsp16 MGP Nsp16 SAM
1 −7.1 −9.6 −7.8 −7.3 −6.9 −11.2 −7.7 −7.7 −7.1
2 −7.3 −8.8 −7.5 −8.1 −7.5 −8 −8.5 −7.6 −7.8
3 −7.2 −9.3 −7.8 −8 −7.5 −9.1 −8.5 −8.3 −8.5
4 −7.9 −7.9 −7.2 −8.5 −7 −8.4 −8.2 −7.1 −8.2
5 −7.1 −7.5 −7.6 −6.9 −6.6 −7.8 −7.8 −6.59 −7.2
6 −7.4 −8 −7.3 −8.5 −7.2 −8.3 −8.4 −6.9 −8.5
7 −7.3 −8.1 −7.3 −9.1 −7.3 −8.4 −8.8 −7.2 −8.7
8 −7.4 −8.1 −7.1 −9.1 −7.1 −8.7 −8.7 −7 −8.7
9 −7.4 −8 −7.1 −8.5 −7.1 −8.5 −8.4 −6.9 −8.6
10 −7.4 −8 −6.8 −8.3 −7 −8.6 −8.1 −7 −8.1
11 −7.8 −8.5 −7.7 −8.7 −7.7 −8.8 −8.2 −6.9 −8.3
12 −7.6 −8.3 −7.2 −8.9 −7.4 −8.7 −8.5 −6.9 −8.4
13 −7.1 −7.6 −7.8 −7.3 −7 −7.9 −7.9 −6.8 −7.3
14 −5.7 −6.6 −5.8 −7 −6 −7.4 −6.3 −7 −6.2
15 −5.2 −5.8 −5.6 −6.7 −5.7 −6.7 −5.9 −5.3 −6
16 −5.2 −5.5 −5.4 −6.1 −6.6 −6.2 −5.6 −4.9 −5.6
17 −5.5 −5.9 −5.4 −6.4 −5.7 −6.6 −5.9 −5.1 −5.9
18 −4.4 −4.9 −4.7 −5.2 −5 −5.1 −5 −4.4 −4.9
19 −4.7 −5.5 −5.1 −5.7 −5.1 −5.2 −6 −4.8 −6
20 −4.9 −5.3 −5 −6 −5.2 −5.4 −5.6 −4.8 −5.4
21 −4.8 −5.4 −6 −5 −5.2 −5.5 −5.9 −5.1 −5.9
22 −6.1 −6.6 −6.9 −7 −5.2 −6.3 −6 −5.3 −6.1
23 −5.2 −6 −5.7 −6.2 −5.2 −5.7 −5.5 −5.7 −5.4
Liganda −8.4 −7.6 −7.4 −5.5 −8.3 −8.2 −10.3 −7.5 −8.4
a

Origin Ligands of Mpro, PLpro, Nsp3AMP, Nsp3MES, RdRp, Nsp14N7-MTase, Nsp16GTA, Nsp16MGP, Nsp16SAM: N3, VIR250, Adenosine Monophosphate (AMP), 2-(N-morpholino)-ethanesulfonic acid (MES), Remdesivir(RTP), Uridine-5′-Monophosphate, S-adenosyl-L-homocysteine (SAH), 7-methyl-GpppA (GTA), 7-methyl-guanosine- 5′-triphosphate (MGP), S-Adenosylmethionine (SAM), respectively.